12.Sherman, KE, et al. Hepatitis C virus prevalence among patients infected with human immunodeficiency virus: a cross-sectional analysis of the US adult AIDS Clinical Trials Group. Clinical Infectious Diseases 2002; 34: 831–837.
13.Puoti, M, et al. Hepatitis B virus co-infection in human immunodeficiency virus-infected subjects. AIDS Reviews 2002; 4: 27–35.
14.Bodsworth, NJ, Cooper, DA, Donovan, B. The influence of humanimmunodeficiency virus type 1 infection on the development of the hepatitis B carrier state. Journal of Infectious Diseases 1991; 163: 1138–1140.
21.Portelinha, Filho AM, et al. Seroprevalence of HBV, HCV and HIV co-infection in selected individuals from state of São Paulo, Brazil. Memorias do Instituto Oswaldo Cruz 2009; 104: 960–963.
22.Anon. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Morbidity and Mortality Weekly Report. Recommendations and Reports 1992; 41: 1–19.
23.Kellerman, SE, et al. Prevalence of chronic hepatitis B and incidence of acute hepatitis B infection in human immunodeficiency virus-infected subjects. Journal of Infectious Disease 2003; 188: 571–577.
24.Chun, HM, et al. Epidemiology of hepatitis B virus infection in a US cohort of HIV-infected individuals during the past 20 years. Clinical Infectious Diseases 2010; 50: 426–436.
25.Anderson, KB, Guest, JL, Rimland, D. Hepatitis C virus coinfection increases mortality in HIV-infected patients in the highly active antiretroviral therapy era: data from the HIV Atlanta VA Cohort Study. Clinical Infectious Diseases 2004; 39: 1507–1513.
26.Barth, RE, et al. Hepatitis B/C and HIV in sub-Saharan Africa: an association between highly prevalent infectious diseases. A systematic review and meta-analysis. International Journal of Infectious Diseases 2010; 14: e1024–1031.
27.Kuniholm, MH, et al. Risk factors and algorithms to identify hepatitis C, hepatitis B, and HIV among Georgian tuberculosis patients. International Journal of Infectious Diseases 2008; 12: 51–56.
28.Dwyre, DM, Fernando, LP, Holland, PV. Hepatitis B, hepatitis C and HIV transfusion-transmitted infections in the 21st century. Vox Sanguinis 2011; 100: 92–98.
29.Victoria, MB, et al. Epidemiology of HIV/HCV coinfection in patients cared for at the Tropical Medicine Foundation of Amazonas. Brazilian Journal of Infectious Diseases 2010; 14: 135–40.
30.Reuter, S, et al. Prevalence and characteristics of hepatitis B and C virus infections in treatment-naïve HIV-infected patients. Medical Microbiology and Immunology 2011; 200: 39–49.
31.Lincoln, D, Petoumenos, K, Dore, GJ. Australian HIV observational database. HIV/HBV and HIV/HCV coinfection, and outcomes following highly active antiretroviral therapy. HIV Medicine 2003; 4: 241–249.
32.Tedaldi, EM, et al. Prevalence and characteristics of hepatitis C virus coinfection in a human immunodeficiency virus clinical trials group: the Terry Beirn Community Programs for Clinical Research on AIDS. Clinical Infectious Diseases 2003; 36: 1313–1317.
33.Dorrucci, M, et al. The effect of hepatitis C on progression to AIDS before and after highly active antiretroviral therapy. AIDS 2004; 18: 2313–2318.
34.Romeo, R, et al. Hepatitis C is more severe in drug users with human immunodeficiency virus infection. Journal of Viral Hepatitis 2000; 7: 297–301.
35.Goodenow, C, Netherland, J, Szalacha, L. AIDS-related risk among adolescent males who have sex with males, females, or both: evidence from a statewide survey. American Journal of Public Health 2002; 92: 203–210.
36.Montgomery, SB, et al. Gender differences in HIV risk behaviors among young injectors and their social network members. American Journal of Drug and Alcohol Abuse 2002; 28: 453–475.
37.Colvin, H, Mitchell, A. Committee on the Prevention and Control of Viral Hepatitis Infections, 2010. Institute of Medicine. Hepatitis and Liver Cancer: a National Strategy for Prevention and Control of Hepatitis B and C.